Company Filing History:
2 out of 3 
1 out of 50 
1 out of 82 
Years Active: 2017-2020
Title: Shinichiro Niwa: Innovator in Therapeutic Agents
Introduction
Shinichiro Niwa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of choroidal neovascularization and various malignant tumors. With a total of 3 patents, his work is paving the way for innovative solutions in medical therapies.
Latest Patents
Niwa's latest patents include a choroidal neovascularization suppressor and a drusen formation suppressor, along with a method for assessing or screening for the same. The existing therapeutic drugs for choroidal neovascularization (CNV) are primarily focused on symptomatic therapy, highlighting the urgent need for radical cure options. His invention provides a prophylactic and therapeutic agent for CNV, utilizing a compound that suppresses epithelial-mesenchymal transition in retinal pigment epithelial cells. Additionally, he has developed a drusen suppressor that employs a similar active ingredient. Another notable patent involves an antibody against the transporter LAT1/CD98, which serves as a therapeutic agent for various malignant tumors, including currently intractable solid tumors.
Career Highlights
Throughout his career, Niwa has worked with notable organizations such as Link Genomics, Inc. and Kinki University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Some of his coworkers include Dai Ogura and Takashi Masuko, who have collaborated with him on various projects, enhancing the impact of his inventions.
Conclusion
Shinichiro Niwa's work in developing therapeutic agents showcases his commitment to addressing critical medical challenges. His innovative patents are a testament to his expertise and dedication to improving patient outcomes.